Articles

  1. Deciphering The Complex Characteristics Of Nanomedicine 5/6/2026

    Gain deeper insight into nanomedicine characterization, showing how critical quality attributes, advanced analytics, and phase‑appropriate strategies drive safety, efficacy, and regulatory readiness.

  2. Innovations In API Manufacturing Of Small Molecule Drugs 5/6/2026

    Read how advances in people, processes, technology, materials, analytics, and sustainability are reshaping small‑molecule API manufacturing to reduce costs, scale efficiently, and meet future demand.

  3. Late‑Stage Progress In Excipients For Precision Nanomedicine 5/6/2026

    View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.

  4. Custom API Manufacturing For Small Molecule And High‑Potency Programs 5/5/2026

    Custom API manufacturing services support small molecule and high‑potency programs with flexible scales, advanced unit operations, and integrated analytical, quality, and regulatory expertise.

  5. Hot Melt Extrusion Solutions To Enhance Drug Product Bioavailability 5/5/2026

    Hot melt extrusion enhances bioavailability of poorly soluble compounds through scalable formulation development, advanced analytics, and end‑to‑end manufacturing from clinical to commercial supply.

  6. Advancing Your Protein 5/5/2026

    Examine how a CMDO with extensive experience can deliver efficient and high-yielding custom protein manufacturing, supporting clients throughout the entire protein development process.

  7. Advancing CRISPR-Based Therapeutic Development 5/5/2026

    A CDMO that manufactures nucleases at research and cGMP grades can eliminate the need for custom manufacturing runs, simplify the transition to clinical application, and reduce regulatory paperwork.

  8. Advancing Innovations For mRNA Medicine Pioneers 5/5/2026

    Translating mRNA sequence to a high-quality drug product presents a complex challenge. Learn how partnering with a single contract manufacturer can alleviate potential delays and risks.

  9. Using Tech Transfer To Accelerate NDA Approval 4/27/2026

    A biotech company accelerated NDA approval for a novel anti‑infective by executing a highly disciplined, first‑time‑right technology transfer and registration batch manufacturing strategy.

  10. Providing Solutions In Titer, Host Cell Protein, And Scalability 4/23/2026

    By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, see how we were able to enable a highly data-driven approach to clone selection and process optimization.